(R)-(-)-1-茚满基异硫氰酸酯 | 737000-97-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 中文名称: (R)-(-)-1-茚满基异硫氰酸酯
• 中文别名: (R)-(-)-1-茚满基硫异氰酸酯；(R)-(-)-1-茚满基硫代异氰酸酯
• 英文名称: (R)-(-)-1-indanyl isothiocyanate
• 英文别名: (1R)-1-isothiocyanato-2,3-dihydro-1H-indene
• CAS: 737000-97-4
• 化学式: C₁₀H₉NS
• 分子量: 175.254
• InChiKey: YQGGEOQEFFXRLO-SNVBAGLBSA-N

物化性质

• 沸点：
  108-113°C 0,1mm
• 密度：
  1,145 g/cm3
• 闪点：
  108-113°C/0.1mm

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  44.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  6.1
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22,R36/37/38
• 危险品运输编号：
  UN 2810
• 海关编码：
  2930909090
• 包装等级：
  III
• 危险类别：
  6.1

反应信息

• 作为反应物：
  描述：

  (R)-(-)-1-茚满基异硫氰酸酯 、 (2-氨基-6-氯苯基)-甲醇 以 四氢呋喃 为溶剂， 反应 21.0h， 生成
  参考文献：
  名称：

  5-SUBSTITUTED BENZOXAZINES

  摘要：

  本发明涉及式(I)的5-取代苯并噁嗪衍生物，其中X、R1和R2如本文所述，以及它们的制备、含有它们的药物组合物。本发明的化合物是5-HT5A受体拮抗剂，可用于预防和/或治疗抑郁症、焦虑障碍、精神分裂症、恐慌障碍、广场恐惧症、社交恐惧症、强迫症、创伤后应激障碍、疼痛、记忆障碍、痴呆症、进食行为障碍、性功能障碍、睡眠障碍、药物滥用、帕金森病等运动障碍、精神障碍或胃肠道障碍的治疗。

  公开号：

  US20100063042A1

文献信息

• 5-substituted benzoxazines
  申请人：Hoffman-La Roche Inc.

  公开号：US08044047B2

  公开（公告）日：2011-10-25

  The present invention is concerned with 5-substituted benzoxazine derivatives of formula (I) wherein X, R1 and R2 are as described herein, as well as their manufacture, pharmaceutical compositions containing them. Compounds of the present invention are 5-HT5A receptor antagonists, and are useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.

  本发明涉及式(I)的5-取代苯并噁唑衍生物，其中X、R1和R2如本文所述，以及它们的制造方法、含有它们的制药组合物。本发明化合物是5-HT5A受体拮抗剂，可用于预防和/或治疗抑郁症、焦虑症、精神分裂症、惊恐障碍、广场恐惧症、社交恐惧症、强迫症、创伤后应激障碍、疼痛、记忆障碍、痴呆症、饮食行为障碍、性功能障碍、睡眠障碍、药物滥用、帕金森病等运动障碍、精神障碍或胃肠道障碍的治疗。
• US8044047B2
  申请人：——

  公开号：US8044047B2

  公开（公告）日：2011-10-25
• [EN] 5-SUBSTITUTED BENZOXAZINES<br/>[FR] BENZOXAZINES 5-SUBSTITUÉES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2010026112A1

  公开（公告）日：2010-03-11

  The present invention is concerned with 5-substituted benzoxazine derivatives of formula (I), wherein X, R1 and R2 are as described herein, as well as their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are 5-HT5A receptor antagonists, useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.
• 5-SUBSTITUTED BENZOXAZINES
  申请人：Kolczewski Sabine

  公开号：US20100063042A1

  公开（公告）日：2010-03-11

  The present invention is concerned with 5-substituted benzoxazine derivatives of formula (I) wherein X, R 1 and R 2 are as described herein, as well as their manufacture, pharmaceutical compositions containing them. Compounds of the present invention are 5-HT 5A receptor antagonists, and are useful in the prevention and/or treatment of depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, abuse of drugs, motor disorders such as Parkinson's disease, psychiatric disorders or gastrointestinal disorders.

  本发明涉及式(I)的5-取代苯并噁嗪衍生物，其中X、R1和R2如本文所述，以及它们的制备、含有它们的药物组合物。本发明的化合物是5-HT5A受体拮抗剂，可用于预防和/或治疗抑郁症、焦虑障碍、精神分裂症、恐慌障碍、广场恐惧症、社交恐惧症、强迫症、创伤后应激障碍、疼痛、记忆障碍、痴呆症、进食行为障碍、性功能障碍、睡眠障碍、药物滥用、帕金森病等运动障碍、精神障碍或胃肠道障碍的治疗。